Mechanism

FLT3;KIT;PKC;PDGFR

Assets acting on this target.

Class
Reversible multitargeted non-covalent kinase inhibitor
Notes
audit finding #658 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT04027309

← all mechanisms